Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Gene therapy to improve migration of T cells to the tumor siteAntonio Di Stasi, Biagio De Angelis, Barbara Savoldo
Best Practice & Research. Clinical Haematology|October 23, 2004
Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative diseaseHelen E Heslop, Barbara Savoldo, Cliona M Rooney
Journal of Personalized Medicine|February 25, 2022
The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin LymphomaJeremy A Meier, Barbara Savoldo, Natalie S Grover
Human Vaccines & Immunotherapeutics|November 15, 2023
Building safety into CAR-T therapyDaniel T Peters, Barbara Savoldo, Natalie S Grover
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
Changes in chemokine receptor expression of regulatory T cells after ex vivo cultureRikhia Chakraborty, Cliona Rooney, Gianpietro Dotti, et al.
Leukemia & Lymphoma|July 7, 2007
What influence has B-cell depletion on viral infections?Anjum S Kaka, Cliona M Rooney, Barbara Savoldo
Immunotargets and Therapy|July 30, 2016
Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapySerena Kimi Perna, Leslie E Huye, Barbara Savoldo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19<sup>+</sup> TumorsNatalie S Grover, Nicholas Tschernia, Gianpietro Dotti, et al.
Immunological Reviews|December 17, 2013
Design and development of therapies using chimeric antigen receptor-expressing T cellsGianpietro Dotti, Stephen Gottschalk, Barbara Savoldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid TumorsGiovanni Fucà, Loic Reppel, Elisa Landoni, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Gene therapy to improve migration of T cells to the tumor siteAntonio Di Stasi, Biagio De Angelis, Barbara Savoldo
Best Practice & Research. Clinical Haematology|October 23, 2004
Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative diseaseHelen E Heslop, Barbara Savoldo, Cliona M Rooney
Journal of Personalized Medicine|February 25, 2022
The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin LymphomaJeremy A Meier, Barbara Savoldo, Natalie S Grover
Human Vaccines & Immunotherapeutics|November 15, 2023
Building safety into CAR-T therapyDaniel T Peters, Barbara Savoldo, Natalie S Grover
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
Changes in chemokine receptor expression of regulatory T cells after ex vivo cultureRikhia Chakraborty, Cliona Rooney, Gianpietro Dotti, et al.
Leukemia & Lymphoma|July 7, 2007
What influence has B-cell depletion on viral infections?Anjum S Kaka, Cliona M Rooney, Barbara Savoldo
Immunotargets and Therapy|July 30, 2016
Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapySerena Kimi Perna, Leslie E Huye, Barbara Savoldo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19<sup>+</sup> TumorsNatalie S Grover, Nicholas Tschernia, Gianpietro Dotti, et al.
Immunological Reviews|December 17, 2013
Design and development of therapies using chimeric antigen receptor-expressing T cellsGianpietro Dotti, Stephen Gottschalk, Barbara Savoldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid TumorsGiovanni Fucà, Loic Reppel, Elisa Landoni, et al.
Pageof 16